GlassScriptPhysician profile
Michael Andrew Hogue
NPI 1902895600
$5,512.04
in general payments reported to CMS, 2019-2025
20 companies · $783 in 2025
The $783 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $522 · 2020: $220 · 2021: $1,429 · 2022: $892 · 2023: $966 · 2024: $701 · 2025: $783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,415 · Entertainment: $34.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,415.27 |
| Entertainment | $34.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $874.52 | 2019-2025 | Clareon, Clareon Panoptix Pro, Simbrinza |
| Abbvie INC. | $734.63 | 2022-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $656.22 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $588.51 | 2022-2024 | Miebo, Xiidra, Vyzulta |
| Sun Pharmaceutical Industries INC. | $569.57 | 2021-2024 | |
| Aerie Pharmaceuticals, INC. | $322.37 | 2021 | |
| Glaukos Corporation | $281.91 | 2023-2025 | Istent Infinite Trabecular Micro-Bypass System Model Is3, Istent Inject Trabecular Micro-Bypass System, Istent Trabecular Micro-Bypass Stent System |
| Allergan, INC. | $261.63 | 2020-2022 | |
| Oyster Point Pharma, INC. | $215.35 | 2022-2025 | Tyrvaya, Ryzumvi |
| Harrow Eye, LLC | $209.55 | 2023-2025 | Vevye |
| Dompe US, INC. | $204.70 | 2025 | Oxervate |
| Eyevance Pharmaceuticals LLC | $179.69 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $152.17 | 2024 | Xdemvy |
| Ocular Therapeutix, INC. | $94.16 | 2021-2025 | Dextenza |
| Novartis Pharmaceuticals Corporation | $43.60 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $34.50 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Tearlab Corp | $30.23 | 2024 | Scoutpro Osmolarity System |
| Apellis Pharmaceuticals, INC. | $24.76 | 2025 | Syfovre |
| Sight Sciences, INC. | $17.15 | 2024 | Omni Surgical System |
| Rxsight INC | $16.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hogue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.